Bristol Myers Squibb BMY paid Tiber Creek Group $30K for lobbying in Q4 2022 · Health Issues, Medicare

Trade details

Type: Lobbying report
Amount: $30,000
Quarter: Q4 2022
Stock: Bristol Myers Squibb BMY
Client: Bristol-Myers Squibb Company
Reported: 23/01/13

$880K on lobbying in 2022

What else happened in Bristol Myers Squibb around then

Filed or reported within 30 days of the trade day · 22/12/01~23/01/30

Bristol-Myers Squibb Company's other lobbying reports

Bristol-Myers Squibb Company
LobbyingBristol Myers Squibb
Lobbying
Bristol Myers Squibb
BMY
$50K
$50K
Reported 07/20
for Q2
Bristol-Myers Squibb Company
LobbyingBristol Myers Squibb
Lobbying
Bristol Myers Squibb
BMY
$80K
$80K
Reported 07/20
for Q2
Bristol-Myers Squibb Company
LobbyingBristol Myers Squibb
Lobbying
Bristol Myers Squibb
BMY
$3.2M
$3.2M
Reported 07/20
for Q2
Bristol-Myers Squibb Company
LobbyingBristol Myers Squibb
Lobbying
Bristol Myers Squibb
BMY
Under $5,000
Under $5,000
Reported 07/20
for Q2
Bristol-Myers Squibb Company
LobbyingBristol Myers Squibb
Lobbying
Bristol Myers Squibb
BMY
$60K
$60K
Reported 07/20
for Q2

Bristol Myers Squibb BMY paid Tiber Creek Group $30K for lobbying in Q4 2022 · Health Issues, Medicare | Whalegun